Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/treatment-of-chronic-nonhealing-neurotrophic-corneal-epithelial-z0hiGh0LUf
References (18)
-
P. Qiu, M. Kurpakus‐Wheater, G. Sosne (2007)
Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migrationJournal of Cellular Physiology, 212
-
A. Lambiase, P. Rama, S. Bonini, Giancarlo Caprioglio, L. Aloe (1998)
Topical treatment with nerve growth factor for corneal neurotrophic ulcers.The New England journal of medicine, 338 17
-
G. Sosne, E. Szliter, R. Barrett, K. Kernacki, H. Kleinman, L. Hazlett (2002)
Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury.Experimental eye research, 74 2
-
K. Malinda, G. Sidhu, H. Mani, K. Banaudha, R. Maheshwari, A. Goldstein, H. Kleinman (1999)
Thymosin β4 Accelerates Wound HealingJournal of Investigative Dermatology, 113
-
G. Sosne, E.A. Szliter, R. Barrett (2002)
Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury, 74
-
G. Sosne, C. Chan, Khoan Thai, Michael Kennedy, E. Szliter, L. Hazlett, H. Kleinman (2001)
Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo.Experimental eye research, 72 5
-
G. Sosne, P. Christopherson, R. Barrett, R. Fridman (2005)
Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury.Investigative ophthalmology & visual science, 46 7
-
A. Lambiase, P. Rama, Luigi Aloe, S. Bonini (1999)
Management of neurotrophic keratopathy.Current opinion in ophthalmology, 10 4
-
Hao Yang, Xipeng Cheng, Q. Yao, Jingwen Li, G. Ju (2008)
The Promotive Effects of Thymosin β4 on Neuronal Survival and Neurite Outgrowth by Upregulating L1 ExpressionNeurochemical Research, 33
-
Daniel Safer, Rajasree Golla, V. Nachmias (1990)
Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets.Proceedings of the National Academy of Sciences of the United States of America, 87 7
-
A. Goldstein, E. Hannappel, H. Kleinman (2005)
Thymosin β4: actin-sequestering protein moonlights to repair injured tissuesTrends in Molecular Medicine, 11
-
I. Bock-Marquette, A. Saxena, Michael White, J. DiMaio, D. Srivastava, D. Srivastava (2004)
Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repairNature, 432
-
K. Malinda, A. Goldstein, Hynda Kueinman (1997)
Thymosin β4 stimulates directional migration of human umbilical vein endothelial cellsThe FASEB Journal, 11
-
K.M. Malinda, G.S. Sidhu, H. Mani (1999)
Thymosin β4 accelerates wound healing, 113
-
G. Sosne, A. Siddiqi, M. Kurpakus‐Wheater (2004)
Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro.Investigative ophthalmology & visual science, 45 4
-
G. Sosne, Lihua Xu, L. Prach, L. Mrock, H. Kleinman, J. Letterio, L. Hazlett, M. Kurpakus‐Wheater (2004)
Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta.Experimental cell research, 293 1
-
John Young, Anthony Lawrence, Andrew MacLean, B. Leung, Iain McInnes, Benito Cañas, Darryl Pappin, R. Stevenson (1999)
Thymosin β 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoidsNature Medicine, 5
-
G. Sosne, P. Qiu, P. Christopherson, M. Wheater (2007)
Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.Experimental eye research, 84 4
- Publisher
- Wiley
- Copyright
- Copyright © 2010 Wiley Subscription Services
- ISSN
- 0077-8923
- eISSN
- 1749-6632
- DOI
- 10.1111/j.1749-6632.2010.05471.x
- pmid
- 20536469
- Publisher site
- See Article on Publisher Site
Abstract
Neurotrophic corneal defects are difficult to heal and all too often lead to scarring and vision loss. Medical management is often of limited success. We describe the results of nine patients (ages 37–84) with chronic nonhealing neurotrophic corneal epithelial defects who were treated with thymosin beta 4 (Tβ4) sterile eye drops for 28 or 49 days with a follow‐up period of 30 days. Those with geographic defects (six patients) showed dramatic healing without clinically significant neovascularization. Stromal thinning was observed in one patient. Three patients with punctate epithelial defects did not have a demonstrable change in their clinical findings. Reduced ocular irritation was reported by all patients soon after treatment initiation. Results from these compassionate use cases indicate that Tβ4 may provide a novel, topical approach to wound healing in chronic nonhealing neurotrophic corneal ulcers.
Journal
Annals of the New York Academy of Sciences – Wiley
Published: Jan 1, 2010
Keywords: ; ; ; ; ; ;